Skip to main content

Antonio Julia Cano

Institutions of which they are part

Head of group
Rheumatology
Vall Hebron Institut de Recerca

Antonio Julia Cano

Institutions of which they are part

Head of group
Rheumatology
Vall Hebron Institut de Recerca

Projects

ID-DarkMatter-NCD: Unraveling the dark matter of infectious diseases, environmental and genetic factors tipping the balance towards NCDs

IP: Antonio Julia Cano
Collaborators: Eros Alejandro Marin Millan
Funding agency: EUROPEAN COMMISSION
Funding: 218825
Reference: ID-DARKMATTER-NCD_HE-HLTH2023
Duration: 01/01/2024 - 31/12/2028

Estratificación de pacientes con artritis reumatoide en la terapia anti-TNF. Caracterización espacial del transcriptoma de la membrana sinovial asociada a la respuesta a tratamiento y asociación a biomarcadores proteómicos.

IP: Antonio Julia Cano
Collaborators: Juan Jose De Agustin De Oro, Nuria Palau Balaña, Adria Aterido Ballonga
Funding agency: Instituto de Salud Carlos III
Funding: 196020
Reference: PI21/01185
Duration: 01/01/2022 - 30/06/2026

DECISION ON OPTIMAL COMBINATORIAL THERAPIES IN IMIDS USING SYSTEMS APPROACHES (DOCTIS)

IP: Sara Marsal Barril
Collaborators: Antonio Julia Cano, Javier Hoyo Pérez, Elena Granell Pallares, Adria Aterido Ballonga, Montse Sender Beleta, Nuria Palau Balaña, Edgar Nuñez Gallardo, Raul Tortosa Mendez, Maria Alba Erra Duran
Funding agency: EUROPEAN COMMISSION
Funding: 1079085
Reference: DOCTIS_H2020_SC1-BHC2019
Duration: 01/01/2020 - 31/12/2025

Biomarcadores de actividad en la artritis reumatoide. Estudio transversal y prospectivo basado en la immunosecuenciación de anticuerpos y receptores TCR.

IP: Antonio Julia Cano
Collaborators: Raul Tortosa Mendez
Funding agency: Instituto de Salud Carlos III
Funding: 147620
Reference: PI17/00019
Duration: 01/01/2018 - 30/06/2022

Related news

Transaction expands Formation Bio's immunology pipeline with Phase 1 ready drug candidate.

15 researchers from the Rheumatology, Systemic Diseases and the Physiology and Pathophysiology of the Digestive Tract groups gave around 25 presentations.

Funded by the European Union, this project coordinated by the Vall d'Hebron Research Institute (VHIR) seeks to develop more effective therapies by creating new combinations of existing drugs

Related professionals

Andrea Pérez Manrique

Andrea Pérez Manrique

Research technician
Basic, Translational and Clinical Pharmacy Research
Read more
Nuria Santamaria Torner

Nuria Santamaria Torner

Tècnic/a Grau Superior
Unitat legal
Legal Directorate
Read more
Cristina Salon Ajenjo

Cristina Salon Ajenjo

Research technician
Donation and transplantation of organs, tissues and cells
Read more
María Delgado Muñoz

María Delgado Muñoz

Research technician
Pediatric Neurology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.